The North America Anastomosis Devices Market would witness Market growth of 4.1% CAGR during the forecast period (2022-2028).
Technological advancements in various medical device companies would aid in the improvement of the functionality and endurance of anastomosis devices. For example, the US Food and Drug Administration (FDA) awarded a self-forming magnetic compression anastomosis device developed by the US-based GI Windows Medical Corp, the Breakthrough Device Designation in November 2020. The device will be utilized to execute an end-to-end minimally invasive anastomosis of the small bowel for ileostomy reversal or tissue resection, allowing it to be used more widely among patients with gastrointestinal problems.
Custom robotic deposition equipment was used to create easy-to-use silk-based resorbable as well as suture-less anastomosis devices. Retention strength, crush resistance, and leak resistance were all high in silk-based heparin-eluting devices. These devices were put to the test in a porcine implant, where they stayed intact. Histological research revealed that the implant wall was degrading and absorbing, indicating that cells were able to enter into the lamellar section of the device, indicating the possibility of tissue regeneration.
The prevalence of several cardiovascular indications, such as coronary artery disease (CAD), strokes, and stomach malignancies, such as adenocarcinoma, lymphoma, and others, is on the rise in this region. As a result, as the number of surgical procedures increased, the demand for surgical devices also grown. According to the American Heart Association, almost 92.1 million people in the United States suffered from cardiovascular disease in 2018, resulting in 3244 heart transplants. As a result, the Market in the region is driven by the increased demand for minimally invasive surgical devices during surgical procedures. Moreover, the increasing number of patients with requirement of surgeries is also owing to the sedentary lifestyle of people across the region.
The US Market dominated the North America Anastomosis Devices Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $1,247.4 million by 2028. The Canada Market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The Mexico Market would showcase a CAGR of 5.5% during (2022 - 2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Anastomosis Devices Market is Estimated to reach $4.8 Billion by 2028, at a CAGR of 5.5%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
